Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C

2011121 citationsJournal Article

Authors

Richard K. Sterling · Virginia Commonwealth University Medical Center

Elizabeth C. Wright · National Institutes of Health

Timothy R. Morgan · VA Long Beach Healthcare System

Leonard B. Seeff · National Institutes of Health

John C. Hoefs · University of California, Irvine

Adrian M. Di Bisceglie · Saint Louis University

Jules L. Dienstag

Abstract

Mild-moderate elevations in total AFP and DCP but not in AFP-L3 occur frequently in patients with chronic hepatitis C and advanced fibrosis, are related to factors other than HCC, and are poor predictors of HCC.

Topics & Keywords

Hepatitis C virus research Liver Disease Diagnosis and Treatment Hepatocellular Carcinoma Treatment and Prognosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The American Journal of Gastroenterology

Volume 107, Issue 1, pp. 64-74

DOI: 10.1038/ajg.2011.312

Field-Weighted Citation Impact: 3.73